“Many Clinical Trials’ Findings Never Get Published. Here’s Why That’s Bad”

0
174

STAT’s watchdogs, Ivan Oransky and Adam Marcus, explain why unpublished studies for drug makers and researchers “put young patients at risk, particularly if those data reveal dangerous side effects or other adverse events from taking medications.”

Article →

unpublished studies

LEAVE A REPLY